HC Juncal: Nuria Caballero Ramrez, Ana Morn Escudero, Mercedes Rodrguez Franco, M Luz Meirio Prez, M Mar Zamora Gmez, Francisco Vivas Rubio, Mara Martn Martn
Spinal Cord Injury BPC 157 has shown great promise in enhancing recovery processes following spinal cord injuries
For a full scientific overview of AHK-Cu, see our research reference page: AHK-Cu Overview Bulk orders automatically save 20% on any 10+ vials (BAC excluded) Important Notice: This product is sold strictly for laboratory research purposes only
Their appropriate utilization assists patients, medical care providers and labs around the world
Low levels can cause a loss of balance, numbness or tingling in the arms and legs, weakness, fatigue, constipation, confusion, depression, poor memory, soreness of the mouth or tongue, weight loss, and a type of anemia known as megaloblastic anemia
Injectable BPC-157: Higher Absorption and Targeted Repair Typical range: 2001,000 mcg per day Common dose: 500 mcg per day Method: Subcutaneous (SubQ) injection near the injury site or abdomen Cycle: 26 weeks depending on injury severity Injectable BPC-157 offers the highest bioavailability and fastest results, especially for tendon, ligament, and muscle injuries